acetaminophen
Coverage of acetaminophen in the Nexus archive.
- FDA approves new over-the-counter pain reliever that combines Tylenol and Naproxen
The FDA approved a new over-the-counter pain reliever combining acetaminophen (Tylenol) and naproxen (Aleve) into a single tablet, offering up to 12 hours of relief for common conditions like headaches and back pain. The medication provides faster and longer-lasting relief than either drug alone but carries risks such as liver damage from acetaminophen and NSAID-related complications from naproxen. Doctors advise careful label reading to avoid overdosing and recommend consulting healthcare providers for those with certain health conditions.
- FDA approves new over-the-counter pain reliever that combines Tylenol and naproxen
The FDA approved the first over-the-counter medication combining acetaminophen (Tylenol) and naproxen (Aleve) into a single tablet for up to 12 hours of pain relief. The combination aims to provide faster and longer-lasting relief for conditions like headaches, back pain, and menstrual cramps, though it carries risks such as liver damage from acetaminophen and NSAID-related complications.
- FDA approves over-the-counter combo of Tylenol and Naproxen for pain relief
The FDA approved an over-the-counter combination of acetaminophen (Tylenol) and naproxen sodium for temporary relief of minor aches and pains in adults and children 12 and older. The opioid-free medication is expected to provide up to 12 hours of pain relief and aligns with President Trump’s Great Health Care Plan to expand non-opioid pain management options.
- FDA approves over-the-counter combo of Tylenol and Naproxen for pain relief
The FDA approved an over-the-counter combination of acetaminophen (Tylenol) and naproxen sodium for temporary relief of minor aches and pains in adults and those aged 12 and older. The opioid-free medication offers up to 12 hours of pain relief per dose and aligns with President Trump’s Great Health Care Plan to expand non-opioid pain management options.
- FDA approves over-the-counter pill that combines Tylenol with naproxen
The FDA approved an over-the-counter pill combining 650mg of Tylenol (acetaminophen) and 220mg of naproxen sodium for temporary pain relief. The tablet is available for adults and children 12+ and offers 12-hour pain control, with Kenvue securing a three-year exclusivity period for the formulation.
- Prenatal exposure to acetaminophen
The article discusses prenatal exposure to acetaminophen. However, the content provided is limited to a directive to 'Read the ruling here,' with no additional details.
- Eminent Psychiatrist Dies; Editing Embryo DNA; Acetaminophen vs Ibuprofen
Eminent psychiatrist Robert Coles, a Harvard University professor and Pulitzer Prize-winning author, has died. He was known for advocating for children affected by poverty. The article also mentions unrelated topics of embryo DNA editing and a comparison between Acetaminophen and Ibuprofen.
- New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine issued new guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting prior warnings from the Trump administration. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to shift autism research toward environmental causes, while the FDA had previously proposed label changes for acetaminophen despite no proven link to autism.
- Medical misinformation on Tylenol in pregnancy spreads faster than safety studies
A Canadian practice paper highlights that recent high-quality evidence reassures pregnant individuals using acetaminophen, emphasizing the importance of null findings in medical research.
- New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine issued new clinical guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting the Trump administration's earlier caution about its potential link to autism. The guidance notes that while some studies associate maternal acetaminophen use with neurodevelopmental risks, causality remains unproven. Health and Human Services Secretary Robert F. Kennedy Jr. has directed the FDA to shift autism research toward environmental causes.
- New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine published new clinical guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting prior Trump administration warnings about its potential link to autism. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to shift autism research toward environmental causes, while Texas' Attorney General Ken Paxton sued Johnson and Johnson over alleged risks of acetaminophen use during pregnancy.
- New medical guidance affirms Tylenol’s safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine released new clinical guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting the Trump administration's earlier caution about potential autism risks. The guidance notes methodological limitations in studies linking acetaminophen to neurodevelopmental issues and emphasizes the risks of untreated maternal fever.
- New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine reaffirmed acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, countering the Trump administration's previous warnings about its potential link to autism. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to focus autism research on environmental causes, while Texas Attorney General Ken Paxton sued Johnson and Johnson over alleged misleading claims about Tylenol's safety during pregnancy.
- New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine published new clinical guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting prior Trump administration warnings about potential autism risks. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to shift autism research toward environmental causes, while the organization emphasized methodological limitations in studies linking acetaminophen to neurodevelopmental outcomes.
- New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine updated its guidance to recommend acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting previous Trump administration warnings about a potential link to autism. The guidance highlights methodological issues in studies suggesting such a link, while the FDA has not yet changed Tylenol's label despite initial plans to do so following Trump's claims.
- New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine updated its guidance to recommend acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, countering previous claims by the Trump administration about its link to autism. The FDA is considering label changes, and a lawsuit against Johnson and Johnson was filed by Texas' Republican Attorney General Ken Paxton.
- New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt
The Society for Maternal-Fetal Medicine reaffirmed acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting the Trump administration's earlier caution about potential autism risks. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to shift autism research toward environmental causes, while the FDA had proposed label changes for acetaminophen products based on unproven autism links.
- US ‘drowning in misinformation’ under RFK Jr, autism advocates say
Health officials in the Trump administration are accused of fueling a 'crisis of public trust' by spreading misinformation linking vaccines and autism, including promoting unproven connections between acetaminophen use during pregnancy and autism. The report calls for congressional oversight hearings and potential impeachment of officials like Robert F Kennedy Jr., the HHS secretary.
- Taking Tylenol during pregnancy has no link to autism, new study finds
A new Danish study finds no link between Tylenol use during pregnancy and autism. The Trump administration had previously claimed a 'very increased risk of autism' from Tylenol use, leading to a decline in its usage among pregnant individuals.